Fixed-annuity guarantees more income for penalty-free early withdrawals from retirement plans.
Nitin Joshi, PhD, shared CAGE Bio’s development of CGB-500 and why phase 2 EASI scores have the company’s scientific advisory board optimistic.
Renata Block, MMS, PA-C, and Faseeha Raza, PA-C, discuss the DPAF, philanthropy, leadership, and the importance of patient care.
Harnessing digital marketing tools can help your medical practice grow.
Sydney Givens, PA-C, reviews how she discusses cosmeceuticals with her patients and what resources she offers.
Misinformation regarding the use of corticosteroids remains persistent and may have implications on patient care.
VYNE recently announced positive results for its novel oral small molecule BD2-selective BET inhibitor in a single-ascending dose clinical trial.
Immunotherapy agent nemvaleukin alfa was granted an FDA fast track designation for the treatment of patient’s mucosal melanoma for previously undergone treatment with an anti-PD-L1 therapy.
Founder Dina El-Sherif, MBA, gave an in-depth overview of the at-home facial rejuvenation device and its 3-step process at AAD 2024.
Gold encourages all attendees to feel welcome as they attend both cosmetic and medical dermatology sessions.
In one-third of cases of psoriasis, disease onset occurs in the first or second decade of life, although it may not be diagnosed until the patient has reached adulthood.
Diego Ruiz Dasilva, MD, FAAD, reviews the unmet needs and barriers in the treatment landscape of atopic dermatitis.
It effects most teenagers and can lead to mental distress. Here are 5 important facts about acne vulgaris in adolescents.
Sexual and gender minority patients with chronic inflammatory skin diseases may be disproportionately influenced by cost and noncost obstacles to health care.
Ronda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.
Researchers sought to expand knowledge of the role of cannabis and its molecular mechanisms in anticancer effects.
Ahmad Amin, MD, FAAD, reviews biologic selection in patients with psoriatic disease.
Learn more about the OX40-OX40L pathway and 2 drugs heading toward phase 3 trials.
Explore how BCs are supported through complex drug approvals and ensuring patients have access to prescribed medications.
Jane Bellet, MD, will present 2 sessions full of pearls to ensure tiny fingers and toes are cared for in a timely, heartfelt, and effective treatment regimen.
Daphne Chan, PhD, MHEcon, discusses the Pathways program, a partnership between the AAD, Janssen, and Kenvue to mentor young, aspiring dermatology providers.
Eli Lilly recently hosted a panel discussion with Olympic athlete Suni Lee to discuss the importance of finding a dermatologist who understands the burden of AD.
An expert in dermatology shares his thoughts on the educational and unmet needs in the identification and management of patients with GPP.